What are you having for lunch today Smokey, burrito's anyone. haha
"Don't fall for the analyst upgrades this company is in serious trouble. The stock deserves a serious haircut from these levels "
They are already rocking a damn mohawk.
Cashing In to Conquer Cancer In the risk-laden world of biotech, Onward Therapeutics has just bagged a hefty NT$900 million—roughly US$28 million—from its Series B financing. That's not pocket change and speaks to the level of confidence their backers have, even as they plant their global headquarters firmly in Taipei since relocating from Switzerland. A Deep Dive...
Continue Reading
One more regulatory gate just swung open for AES, and this deal is finally staring at the finish line instead of wandering through the usual approval swamp. The Federal Energy Regulatory Commission has issued its final order approving AES's acquisition by a consortium led by Global Infrastructure Partners, part of BlackRock, and EQT Infrastructure VI. The last major...
Continue Reading
The Power Play You Didn't See Coming AMPERA and Berto just made a move that could stir up some serious waves in the energy sector. They've inked a business combination deal set to push advanced energy technology to the forefront. With AMPERA's valuation clocking in at roughly $900 million, this partnership aims to bring cutting-edge power solutions from concept to market....
Continue Reading
A headquarters wall can say more about a company than another polished mission statement ever will. On November 17, 2026, GALLS® unveiled the National Law Enforcement Officer Hall of Fame Wall at its Lexington, Kentucky, corporate headquarters, displaying portraits of every past inductee into the National Law Enforcement Officer Hall of Fame. Recognition, made permanent...
Continue Reading
Tenax Therapeutics in Hot Water Over Drug Trial Results Amidst the ever-unpredictable tides of the pharmaceutical industry, here comes a doozy – Tenax Therapeutics, Inc. is neck-deep in a shareholder lawsuit. If you tossed some money at NASDAQ:TENX anytime between November 13, 2023, and August 7, 2026, you might be feeling the sting of regret, and rightly so. What Went...
Continue Reading
Numbers this lopsided in relapsed Ewing sarcoma make me sit up straight, even after years of watching oncology releases try to turn every blip into a brass band. Inhibrx has reported updated Phase 1/2 data for ozekibart, paired with irinotecan and temozolomide, that look genuinely notable in a disease where patients have very few good cards left to play. That matters...
Continue Reading
Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...
Continue Reading
Brain-tumor progress rarely arrives with a clean victory lap, but the longer INDIGO readout gives clinicians and sector watchers something sturdier than a one-time headline. Servier presented extended Phase 3 results for VORANIGO, or vorasidenib, at the Society for Neuro-Oncology meeting in Philadelphia on November 14 and 15, 2026. The central message is durable benefit...
Continue Reading
Nine cents is the whole message—for the moment Texas Community Bancshares has put a little extra cash on the table, declaring a regular quarterly dividend of $0.06 per common share and a special cash dividend of $0.03 per share. Together, holders get $0.09 per share, payable on or about December 15, 2026, provided they are shareholders of record when business closes on...
Continue Reading
Elah Holdings Drops Their Q3 2026 Numbers Eat your heart out, folks—Elah Holdings has just dropped their third quarter report for 2026, and it caught some eyes. This ain't your run-of-the-mill, brush-right-past-it release. They're out there, waving their flag high in the competitive marketplace, trying to tell us they mean business. If you missed the announcement, they...
Continue Reading
Refurbished Smartphone Market Expectations The market for refurbished smartphones is projected to soar to USD 187.86 billion by 2032, up from an initial estimate of USD 71.67 billion in 2023. This remarkable growth highlights a shift in consumer behaviors and an increasing preference for sustainable technology options. Against this backdrop, experts forecast a solid...
Continue Reading
Hoth Therapeutics Innovates with HT-001 for Patient Care Hoth Therapeutics is making significant strides in oncology with its innovative drug HT-001, meticulously developed to ease dermatological side effects associated with MENIN inhibitors, a class of oncology drugs gaining traction in treating acute leukemias and specific solid tumors. The aim is to allow patients to...
Continue Reading
Voltage Energy's Battle in the Legal Trenches Alright, folks, what we’ve got here is Voltage Energy throwing down the gauntlet against Shoals Technologies in a courtroom saga that’s heated up to a full blaze. Picture this: a North Carolina courtroom where Voltage got a less-than-welcome verdict in their patent fight—now they’re not just taking it lying down....
Continue Reading
Positive Market Trends for Major Banks In the latest trading session, shares of Bank of America Corp (BAC) and Wells Fargo & Co (WFC) experienced notable gains. The surge can be attributed to a widespread rally across the market, which lifted major indices like the S&P 500 and Nasdaq-100 to impressive new heights. Understanding Investor Optimism Investor enthusiasm is...
Continue Reading
Zig-Zag Launches Exciting Holiday Promotions Zig-Zag, a renowned name in the rolling paper industry with over 140 years of craftsmanship, has officially rolled out its highly anticipated "12 Days of Zig-Zag" promotion. This initiative highlights an exclusive range of products available on their new dedicated apparel and accessories website. The promotion features special...
Continue Reading